General Info
Jasper Bos is a General Partner at Forbion, focusing on the firm’s Growth Fund. He has been involved in notable transactions including the sale of Prexton Therapeutics and Epitherapeutics, as well as the IPOs of Translate bio and Progny. With a background as a former Merck executive, Jasper Bos holds a PhD in Pharmacy from the University of Groningen. His investment check size, geographical preference, and partnership styles were not explicitly mentioned in the available information.
Location: Amsterdam, Netherlands
Country: Netherlands
Industries: Life Sciences, BioEconomy
Investment Regions: EU
Investment Stages: pre-seed, seed
Website: https://www.forbion.com/
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a board appointment showing Jasper Bos joined the CellCentric board in May 2025 (investment/board involvement with CellCentric). That is within 6 months of the reference date, indicating very recent activity (investment/board involvement in CellCentric). Therefore tag is very-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Jasper Bos
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI